Sfoglia per AUTORE
INDOLFI C
Collezione ASL Torino 3

  

Items : 7

Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry. in European journal of preventive cardiology / Eur J Prev Cardiol. 2024 Nov 11;31(15):1806-1816. doi: 10.1093/eurjpc/zwae170.

2024
ASL Torino 3
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Dell'Anno R; Merolla A; Iannone FP; Vallefuoco G; Romano A; Passaretti G; Testa C; Cuomo G; Perrone-Filardi P; Paolillo S; Salvatore M; Prastaro M; Soricelli A; Nardi E; Parlati ALM; Buonocore D; Marzano F; Fontanarosa S; Bilato C; Indolfi C; Paloscia L; Brunetti ND; Crisci M; Casu G; De Luca L; Merlini PA; Quarta R; Maloberti A; Porto I; et alii...

Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT). in Atherosclerosis / Atherosclerosis. 2023 Feb;366:32-39. doi: 10.1016/j.atherosclerosis.2023.01.001. Epub 2023 Jan 13.

2023
ASL Torino 3

Brunetti ND; Corleto A; D'Alleva A; Varbella F; Paloscia L; Zito AP; Ciccone MM; Iannuzzo G; Maloberti A; Merlini PA; Spirito G; Catalano A; Spaccarotella CAM; Paolillo S; Vicidomini F; Abbate V; Asile G; Marzano F; Buonocore D; Cesaro A; Gargiulo P; Basile C; Corbo MD; Calabrò P; Indolfi C; Perrone-Filardi P;

SAFETY OF PCSK9I IN A SINGLE COUNTRY, MULTICENTER, OBSERVATIONAL STUDY: A POST-HOC ANALYSIS OF THE AT-TARGET-IT STUDY in European Heart Journal, Supplement

2022
ASL Torino 3

Buonocore D; Basile C; Calabró P; Marzano F; Asile G; Abbate V; Vicidomini F; Paolillo S; Catalano A; Merlini PA; Iannuzzo G; Ciccone MM; Paloscia L; Varbella F; Brunetti ND; Indolfi C; Gargiulo P; Filardi PP;

ADHERENCE AND PERSISTENCE OF PCSK9 INHIBITORS IN CLINICAL PRACTICE: THE REAL-WORLD ITALIAN EXPERIENCE (AT-TARGET-IT STUDY) in European Heart Journal, Supplement

2022
ASL Torino 3

Marzano F; Basile C; Paolillo S; Cesaro A; Buonocore D; Asile G; Abbate V; Vicidomini F; Spaccarotella CAM; Spirito G; Maloberti A; Iannuzzo G; Ciccone MM; Dálleva A; Corleto A; Brunetti ND; Indolfi C; Gargiulo P; Perrone-filardi P;

[Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts]. in Giornale italiano di cardiologia (2006) / G Ital Cardiol (Rome). 2020 Apr;21(4 Suppl 1):3S-21S. doi: 10.1714/3331.33006.

2020
ASL Asti
ASL Torino 3
AO Ordine Mauriziano
ASL Vercelli
AOU Città della Salute di Torino

Pisciotta L; Pirro M; Filardi PP; Mureddu GF; Menozzi A; Marcucci R; Indolfi C; Imbalzano E; Guardigli G; Ferlini M; Faggiano P; Chiarella F; Casu G; Calabrò P; Brunetti ND; Bilato C; Arca M; Musumeci G; Zambon A; Lettino M; Scherillo M; Suppressa P; Uguccioni M; Varbella F; Gentile L; Rapezzi C; Averna M;

Two-year clinical outcomes of the "Italian diffuse/multivessel disease absorb prospective registry" (IT-DISAPPEARS). in International journal of cardiology / Int J Cardiol. 2019 Sep 1;290:21-26. doi: 10.1016/j.ijcard.2019.04.095. Epub 2019 May 3.

2019
ASL Torino 3

Loi B; Fischietti D; Tomai F; Indolfi C; Calabria P; Bartorelli AL; Ribichini F; Cortese B; Varbella F; Nicolini E; Leoncini M; Testa L; De Carlo M; Tarantini G; Bedogni F; Petronio AS;

[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation]. in Giornale italiano di cardiologia (2006) / G Ital Cardiol (Rome). 2018 Sep;19(9):519-529. doi: 10.1714/2951.29672.

2018
ASL Torino 3
AO Ordine Mauriziano
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Musumeci G; Fraccaro C; Franzone A; Castiglioni B; La Manna A; Limbruno U; Berti S; Vigna C; Vignali L; Valva G; Varbella F; Valenti R; Valsecchi O; Trani C; Tomai F; Tolaro S; Tesorio TNM; Tamburino C; Stabile A; Spedicato L; Siviglia M; Scalise F; Sardella G; Satullo G; Rosso R; Saccà S; Sacra C; Santarelli A; Reimers B; et alii...